Urology

Search results

• John Wiley & Sons : Globalization of Cancer Clinical Trials Linked to Lower Enrollment of Black Patients

  Matthew Galsky

  8/03/21

  4 items of Media coverage

  Press/Media

• Globalization of cancer clinical trials linked to lower enrollment of Black patients

  Matthew Galsky,

  8/03/21

  4 items of Media coverage

  Press/Media

• Mount Sinai Experts Address the Biological Causes of Racial Disparities in Prostate Cancer

  Ashutosh Tewari

  18/02/21

  1 item of Media coverage

  Press/Media

• Sema4 Taps William Oh as Chief Medical Science Officer

  William Oh

  24/01/21 → 29/01/21

  2 items of Media coverage

  Press/Media

• Sema4 Appoints William Oh as Chief Medical Science Officer

  William Oh

  25/01/21

  1 item of Media coverage

  Press/Media

• Sema4 Names William Oh as Chief Medical Science Officer

  William Oh

  18/01/21 → 19/01/21

  2 items of Media coverage

  Press/Media

• Oncologist William K. Oh named chief medical science officer at Sema4

  William Oh

  18/01/21

  1 item of Media coverage

  Press/Media

• Sema4 Appoints Renowned Oncologist William Oh, M.D. as Chief Medical Science Officer

  William Oh

  13/01/21 → 14/01/21

  12 items of Media coverage

  Press/Media

• Sema4 : Appoints Renowned Oncologist William Oh, M.D. as Chief Medical Science Officer

  William Oh

  14/01/21

  2 items of Media coverage

  Press/Media

• Follow the Money: Home COVID-19 Tests, Handheld Diagnostics, Digital Pathology

  Michael Palese, & Steven Kaplan,

  21/12/20

  2 items of Media coverage

  Press/Media

• Urology in 2020: PARP inhibitors make a splash as COVID-19’s impact is felt throughout specialty

  Steven Kaplan,

  9/12/20

  1 item of Media coverage

  Press/Media

• A Pilot Study of 5-AZA and ATRA for Prostate Cancer With PSA-only Recurrence After Local Treatment

  William Oh

  11/11/20

  1 item of Media coverage

  Press/Media

• Atezolizumab Given in Combination With a Personalized Vaccine in Patients With Urothelial Cancer

  Matthew Galsky

  6/11/20

  1 item of Media coverage

  Press/Media

• Mount Sinai Receives $4 Million Gift to Support Prostate Health and Urology Department

  Michael Palese, & Steven Kaplan,

  28/10/20

  3 items of Media coverage

  Press/Media

• Prostate Cancer Intensive, Non-Cross Reactive Therapy (PRINT) for Castration Resistant Prostate Cancer (CRPC)

  William Oh

  27/10/20

  1 item of Media coverage

  Press/Media

• Tackling Dangerous Drug Shortages

  Ashutosh Tewari

  22/10/20

  2 items of Media coverage

  Press/Media

• Mount Sinai Study Shows Novel Surgical Technique For Prostate Cancer Improves Urinary Continence

  Ashutosh Tewari

  16/10/20

  1 item of Media coverage

  Press/Media

• Deirdre J. Cohen, MD, MS, Appointed as Director of...

  Ramon Parsons, & William Oh

  30/09/20

  1 item of Media coverage

  Press/Media

• United States : Opdivo (nivolumab) Significantly Improves Disease Free-Survival vs. Placebo as Adjuvant Therapy for Patients with High-Risk, Muscle-Invasive Urothelial Carcinoma in Phase 3 CheckMate -274 Trial

  Matthew Galsky,

  30/09/20

  1 item of Media coverage

  Press/Media

• Bristol Myers Squibb's Opdivo cuts relapse risk in muscle-invasive bladder cancer

  Matthew Galsky,

  25/09/20 → 29/09/20

  2 items of Media coverage

  Press/Media

• Deirdre J. Cohen, MD, MS, Appointed as Director of Gastrointestinal...

  Ramon Parsons, & William Oh

  29/09/20

  10 items of Media coverage

  Press/Media

• Deirdre J. Cohen, MD, MS, Appointed as Director of Gastrointestinal Oncology Program of Mount Sinai Health System.

  Ramon Parsons, & William Oh

  29/09/20

  1 item of Media coverage

  Press/Media

• Bristol Myers Squibb’s phase 3CheckMate -274 trial of Opdivo in patients with high-risk, muscle-invasive urothelial carcinoma meets primary endpoionts

  Matthew Galsky,

  26/09/20

  1 item of Media coverage

  Press/Media

• Bristol Myers Squibb's phase 3CheckMate -274 trial of Opdivo in patients with high-risk, muscle-invasive urothelial carcinoma meets primary endpoionts

  Matthew Galsky,

  26/09/20

  1 item of Media coverage

  Press/Media

• -Bristol Myers Squibb - Opdivo Significantly Improves Disease Free-Survival vs. Placebo as Adjuvant Therapy

  Matthew Galsky,

  25/09/20

  1 item of Media coverage

  Press/Media